Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Epilepsia ; 52(11): 2094-104, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21906051

RESUMEN

PURPOSE: Statins are selective inhibitors of 3-hydroxyl-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase, the rate-limiting enzyme of the mevalonate pathway for cholesterol biosynthesis. Increasing evidence indicates that statins, particularly atorvastatin, are neuroprotective in several conditions, including stroke, cerebral ischemia, traumatic brain injury, and excitotoxic amino acid exposure. However, only a few studies have investigated whether statins modulate seizure activity. In the current study we investigated whether atorvastatin or simvastatin alters the seizures induced by pentylenetetrazol (PTZ), a classical convulsant. METHODS: Adult male Wistar rats were treated with atorvastatin or simvastatin for 7 days (10 mg/kg/day). Seizure activity was induced by PTZ (60 mg/kg, i.p.), and evaluated by behavioral and electrographic methods. Cholesterol levels were determined by a standard spectrophotometric method. Blood-brain barrier (BBB) permeability was assessed by the fluorescein method. Atorvastatin levels in the plasma and cerebral cortex were determined by high-performance liquid chromatography tandem mass spectrometry. KEY FINDINGS: We found that oral atorvastatin treatment increased the latency to PTZ-induced generalized seizures. In contrast, when the 7-day atorvastatin treatment was withheld for 1 day (i.e., atorvastatin withdrawal), PTZ-induced seizures were facilitated, as evidenced by a decrease in the latency to clonic and generalized tonic-clonic seizures induced by PTZ. In contrast, simvastatin treatment for 7 days (10 mg/kg/day, p.o.), with or without withdrawal, did not alter PTZ-induced seizures. Interestingly, the effects of atorvastatin treatment and withdrawal were not accompanied by changes in plasma or cerebral cortex cholesterol levels or in the BBB permeability. Atorvastatin levels in the plasma and cerebral cortex after 7 days of treatment were above the half maximal inhibitory concentration for inhibition of HMG-CoA reductase, whereas atorvastatin was not detectable in the plasma or cerebral cortex following a 24 h washout period (atorvastatin withdrawal). SIGNIFICANCE: We conclude that atorvastatin treatment and withdrawal have differential effects on pentylenetetrazol-induced seizures, which are not related to changes in plasma or cerebral cortex cholesterol levels or in BBB permeability. Additional studies are necessary to evaluate the molecular mechanisms underlying our findings as well as its clinical implications.


Asunto(s)
Anticonvulsivantes/farmacología , Convulsivantes/farmacología , Ácidos Heptanoicos/farmacología , Pentilenotetrazol/farmacología , Pirroles/farmacología , Convulsiones/tratamiento farmacológico , Animales , Anticonvulsivantes/administración & dosificación , Anticonvulsivantes/análisis , Anticonvulsivantes/sangre , Atorvastatina , Barrera Hematoencefálica/metabolismo , Corteza Cerebral/química , Colesterol/sangre , Electroencefalografía , Ácidos Heptanoicos/administración & dosificación , Ácidos Heptanoicos/análisis , Ácidos Heptanoicos/sangre , Masculino , Pirroles/administración & dosificación , Pirroles/análisis , Pirroles/sangre , Ratas , Ratas Wistar , Convulsiones/inducido químicamente , Simvastatina/administración & dosificación , Simvastatina/farmacología
2.
Epilepsia ; 50(4): 811-23, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19055495

RESUMEN

PURPOSE: In the present study we decided to investigate whether physical exercise protects against the electrographic, oxidative, and neurochemical alterations induced by subthreshold to severe convulsive doses of pentyltetrazole (PTZ). METHODS: The effect of swimming training (6 weeks) on convulsive behavior induced by PTZ (30, 45, and 60 mg/kg, i.p.) was measured and different electrographic electroencephalography (EEG) frequencies obtained from freely moving rats. After EEG recordings, reactive oxygen species (ROS) generation, nonprotein sulfhydryl (NPS), protein carbonyl, thiobarbituric acid-reactive substances (TBARS), superoxide dismutase (SOD), catalase (CAT), Na(+), K(+)-ATPase activity, and glutamate uptake were measured in the cerebral cortex of rats. RESULTS: We showed that physical training increased latency and attenuated the duration of generalized seizures induced by administration of PTZ (45 mg/kg). EEG recordings showed that physical exercise decreased the spike amplitude after PTZ administration (all doses). Pearson's correlation analysis revealed that protection of physical training against PTZ-induced seizures strongly correlated with NPS content, Na(+), K(+)-ATPase activity, and glutamate-uptake maintenance. Physical training also increased SOD activity, NPS content, attenuated ROS generation per se, and was effective against inhibition of Na(+), K(+)-ATPase activity induced by a subthreshold convulsive dose of PTZ (30 mg/kg). In addition, physical training protected against 2',7'-dichlorofluorescein diacetate (DCFH-DA) oxidation, TBARS and protein carbonyl increase, decrease of NPS content, inhibition of SOD and catalase, and inhibition glutamate uptake induced by PTZ. CONCLUSIONS: These data suggest that effective protection of selected targets for free radical damage, such as Na(+), K(+)-ATPase, elicited by physical training protects against the increase of neuronal excitability and oxidative damage induced by PTZ.


Asunto(s)
Terapia por Ejercicio/métodos , Estrés Oxidativo/fisiología , Convulsiones/enzimología , Convulsiones/prevención & control , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Natación , Análisis de Varianza , Animales , Conducta Animal , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Catalasa/metabolismo , Modelos Animales de Enfermedad , Electroencefalografía , Fluoresceínas , Ácido Glutámico/metabolismo , Masculino , Estrés Oxidativo/efectos de los fármacos , Pentilenotetrazol , Carbonilación Proteica/efectos de los fármacos , Ratas , Ratas Wistar , Tiempo de Reacción/efectos de los fármacos , Tiempo de Reacción/fisiología , Especies Reactivas de Oxígeno/metabolismo , Convulsiones/inducido químicamente , Estadística como Asunto , Superóxido Dismutasa/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
3.
Behav Brain Res ; 193(2): 306-10, 2008 Nov 21.
Artículo en Inglés | MEDLINE | ID: mdl-18573545

RESUMEN

Traumatic brain injury (TBI) is a devastating disease that commonly causes persistent mental disturbances and cognitive deficits. Although studies indicate that oxidative stress and functional deficits occurring after TBI are interrelated events, the knowledge of the mechanisms underlying the development of such cognitive deficits has been limited. Thus, in the present study, we investigated the effect of fluid percussion brain injury (FPI) on a spatial learning task and levels of oxidative stress markers, namely, protein carbonylation and thiobarbituric acid-reactive substances (TBARS) and Na+,K+-ATPase activity 1 or 3 months after FPI in rats. Statistical analysis revealed that FPI increased the scape latency and mean number of error in Barnes maze test 1 and 3 months after FPI. We also found that protein carbonylation and TBARS content increased in the parietal cortex 1 and 3 months after FPI. In addition, 3 months after FPI, protein carbonylation levels increased both in ipsilateral and contralateral cortices of FPI animals. Indeed, statistical analysis revealed a decrease in Na+,K+-ATPase activity in the cerebral cortex of 1 month FPI animals. Furthermore, the decrease in enzyme activity found 3 months was larger, when compared with 1 month after FPI. These results suggest that cognitive impairment following TBI may result, at least in part, from increase of two oxidative stress markers, protein carbonylation and TBARS that occurs concomitantly to a decrease in Na+,K+-ATPase activity.


Asunto(s)
Conducta Animal/fisiología , Lesiones Encefálicas/fisiopatología , Corteza Cerebral/fisiopatología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Animales , Edema Encefálico/fisiopatología , Lesiones Encefálicas/complicaciones , Lesiones Encefálicas/metabolismo , Corteza Cerebral/lesiones , Corteza Cerebral/metabolismo , Modelos Animales de Enfermedad , Presión Intracraneal/fisiología , Masculino , Aprendizaje por Laberinto/fisiología , Memoria/fisiología , Estrés Oxidativo , Carbonilación Proteica , Ratas , Ratas Wistar , Conducta Espacial/fisiología , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
4.
Neurosci Lett ; 388(1): 21-6, 2005 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-16039050

RESUMEN

The studies of physiological roles for cellular prion protein (PrP(c)) have focused on possible functions of this protein in the CNS, where it is largely expressed. However, the observation that PrP(c) is expressed also in muscle tissue suggests that the physiological role of PrP(c) might not be limited to the central nervous system. In the present study, we investigated possible functions of PrP(c) in muscle using PrP(c) gene (Prnp) null mice (Prnp(0/0)). For this purpose, we submitted Prnp(0/0) animals to different protocols of exercise, and compared their performance to that of their respective wild-type controls. Prnp(0/0) mice showed an exercise-dependent impairment of locomotor activity. In searching for possible mechanisms associated with the impairment observed, we evaluated mitochondrial respiration (MR) in skeletal or cardiac muscle from these mice during resting or after different intensities of exercise. Baseline MR (states 3 and 4), respiratory control ratio (RCR) and mitochondrial membrane potential (DeltaPsi) were evaluated and were not different in skeletal or cardiac muscle tissue of Prnp(0/0) mice when compared with wild-type animals. We concluded that Prnp(0/0) mice show impairment of swimming capacity, perhaps reflecting impairment of muscular activity under more extreme exercise conditions. In spite of the mitochondrial abnormalities reported in Prnp(0/0) mice, our observation seems not to be related to MR. Our results indicate that further investigations should be conducted in order to improve our knowledge about the function of PrP(c) in muscle physiology and its possible role in several different neuromuscular pathologies.


Asunto(s)
Respiración de la Célula/fisiología , Tolerancia al Ejercicio/genética , Mitocondrias/metabolismo , Músculo Esquelético/metabolismo , Miocardio/metabolismo , Proteínas PrPC/metabolismo , Animales , Respiración de la Célula/genética , Radicales Libres/metabolismo , Masculino , Potenciales de la Membrana/genética , Ratones , Mitocondrias/genética , Actividad Motora/genética , Músculo Esquelético/fisiopatología , Estrés Oxidativo/genética , Natación/fisiología
5.
J Pain ; 11(6): 545-54, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20356800

RESUMEN

UNLABELLED: Oxidative stress markers are thought to be related to nociception. Because thiolic compounds are important antioxidants, we investigated the relationship between thiols, endogenous or exogenous, and nociception. Systemic or spinal, but not peripheral, administration of the exogenous thiolic compound N-acetyl-L-cysteine (NAC) reduced nociception induced by intraplantar capsaicin injection. Moreover, we detected an increase in lipid peroxidation and 3-nitrotyrosine and a decrease in nonprotein thiolic levels in the lumbar spinal cord of capsaicin-injected animals. All these effects were prevented by NAC treatment (i.p. and i.t.). Our findings confirm a role for the spinal cord in NAC actions because systemic NAC administration also reduced the nociception trigged by intrathecal injection of capsaicin. Moreover, adjuvant-induced arthritis, but not paw incision, also -decreases nonprotein thiol levels in the spinal cord. Similarly, NAC produced antinociception in adjuvant-treated animals, but not in paw-incised animals. Finally, we investigated the role of endogenous thiol compounds in the nociceptive process administrating buthionine-suphoxamine (BSO), an inhibitor of glutathione-synthesis. Intrathecal BSO treatment decreased nonprotein thiol levels in the spinal cord, as well as induced mechanical allodynia and chemical and thermal hyperalgesia. In conclusion, our results indicate a critical role for nonprotein thiols in nociception at the level of the spinal cord. PERSPECTIVE: The results presented here indicate that the loss of nonprotein thiols in the spinal cord is involved in pain development. Therefore, the administration of thiolic compounds or other strategies allow thiol levels to be maintained and could be a beneficial action in the therapy of painful conditions.


Asunto(s)
Dolor/metabolismo , Médula Espinal/metabolismo , Compuestos de Sulfhidrilo/metabolismo , Acetilcisteína/administración & dosificación , Acetilcisteína/farmacología , Enfermedad Aguda , Analgésicos/administración & dosificación , Analgésicos/farmacología , Animales , Antimetabolitos/farmacología , Artritis Experimental/complicaciones , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/metabolismo , Conducta Animal/efectos de los fármacos , Butionina Sulfoximina/farmacología , Capsaicina , Modelos Animales de Enfermedad , Femenino , Traumatismos de los Pies/complicaciones , Traumatismos de los Pies/tratamiento farmacológico , Traumatismos de los Pies/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Peroxidación de Lípido/fisiología , Vértebras Lumbares , Masculino , Ratones , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/fisiología , Dolor/tratamiento farmacológico , Dolor/etiología , Médula Espinal/efectos de los fármacos , Compuestos de Sulfhidrilo/administración & dosificación , Compuestos de Sulfhidrilo/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA